Finalists of the 2015 Reaxys® PhD Prize Announced

Posted by pt91 at Jun 18, 2015 09:25 AM |
University of Leicester Chemistry postgraduate among those shortlisted for prestigious prize

Issued by Elsevier on 11 June 2015

New York, June 11, 2015– Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the 45 finalists for the 2015 Reaxys PhD Prize. Selected from over 450 submissions from around the globe, these 45 talented chemists join the Reaxys Prize Club; a community of inspiring minds making meaningful contributions to chemistry. As part of this community, the finalists have the opportunity to share their work, connect with internationally recognized chemists and drive their research forward.

All 45 finalists are invited to present their research at the 2015 Reaxys PhD Prize Symposium, September 7-8, 2015, in Hong Kong. Travel bursaries will be provided to support attendance and registration fees. As a new element of the Symposium, a small number of the finalists will be asked to give oral presentations. From the presentations, the Reaxys Advisory Board and prize coordinators will select the three final winners of the 2015 Reaxys PhD Prize based on the originality, innovation, relevance and methodological rigor of the presented work. The winners will be recognized at the awards banquet following the Symposium.

In its sixth year, the Reaxys PhD Prize recognizes chemistry PhD students and recent graduates, the prize continues to foster creativity in groundbreaking chemistry by identifying the chemistry leaders of tomorrow and empowering them to magnify the impact of their work.

“This year we are shining a brighter spotlight on the extraordinary research that comes together for this prestigious award,” explains Prof. Dr. Martin Jansen, Director Emeritus of the Max Planck Institute for Solid State Research in Stuttgart, Germany. As a member of the review board, he has managed the review and decision process along with other board members, all world-renowned chemists. “We also aim to enhance the experience for our new finalists and other attendees by having our Symposium at an international venue that fuels cutting-edge chemistry,” says Jansen.

For more information about the Reaxys PhD Prize and Symposium, visit  The Reaxys® solutions empower early discovery in drug development with access to over 500 million published experimental facts on compounds, reactions and bioactivity, including structure–activity relationship (SAR) data supporting hit identification, lead optimization and synthesis planning. For more information about Reaxys, visit

This year's finalists are:

Jonathan Bauer from the Strohmann group, Dortmund University of Technology

Keith Bentley from the Wolf group, Georgetown University

Nicholas Bruno from the Buchwald group, Massachusetts Institute of Technology (MIT)

Matthew Burns from the Aggarwal group, University of Bristol

Cecilia Casadei from the Raven and Moody groups, Leicester, and the Blakeley group, Grenoble.

Pavla Eliasova from the Čejka group, Charles University

Patrick Fier from the Hartwig group, University of California Berkeley

Meng Gao from the Lei group, Wuhan University

Alvaro Gutierrez Bonet from the Martin group, Institute of Chemical Research of Catalonia (ICIQ)

William Hart-Cooper from the Bergman and Raymond groups, University of California Berkeley

Hiroki Hayashi from the Ishihara group, Nagoya University

Jian He from the Yu group, Scripps Research Institute

Tomohiro Higashino from the Osuka group, Kyoto University

Yunzhe Jiao from the Jones group, University of Rochester

Andrew Jupp from the Goicoechea group, University of Oxford

Eric Keske from the Crudden group, Queen's University

Alexander Kilpatrick from the Cloke group, University of Sussex

Sandra King from the Herzon group, Yale University

Peter Korevaar from the Meijer group, Eindhoven University of Technology

Matthew Langton from the Beer group, University of Oxford

Hsin-Yu Lee from the Wong group, National Taiwan University

Gang Li from the Norton group, Columbia University

Lauren Longobardi from the Stephan group, University of Toronto

Javier López Andarias from the Martín group, Universidad Complutense de Madrid

Titus Masese from the Uchimoto group, Kyoto University

Chiara Musumeci from the Samorì group, University of Strasbourg

Kelli Ogawa from the Boydston group, University of Washington

Steven O'Sullivan from the Murphy group, University of Strathclyde

Henry Pepper from the George group, University of Adelaide

Brandon Rosen from the Baran group, Scripps Research Institute

Tanmoy Saha from the Talukdar group, Indian Institute of Science Education & Research, Pune

Alexander Schoedel from the Zaworotko group, University of South Florida

Sivaprakash Sengodan from the Kim group, Ulsan National Institute of Science and Technology (UNIST)

Indranil Sinha from the Mueller group, University of Muenster

John Tellis from the Molander group, University of Pennsylvania

Shigenobu Umemiya from the Hayashi group, Tohoku University

Daiki Umeyama from the Kitagawa group, Kyoto University

Shin-nosuke Uno from the Urano group, University of Tokyo

Amit Vernekar from the Mugesh  group, Indian Institute of Science

Thorsten vom Stein from the Leitner group, RWTH Aachen University

Xiao-Ye Wang from the Pei group, Peking University

Jens Willwacher from the Fürstner group, Max-Planck-Institut für Kohlenforschung

Tomohiro Yasukawa from the Kobayashi group, University of Tokyo

Chenjie Zeng from the Jin group, Carnegie Mellon University

Taotao Zou from the Che group, University of Hong Kong


About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey — and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across

Reaxys is a trademark of Reed Elsevier Properties SA, used under license.

Media contact

Amy Burnis

Director, Strategic Communications


+ 1617 803 8344

Share this page: